Kazakhstan sets fixed prices for 105 medicinal products and medical devices

Print 26 May 2017
GMP News

On May 23, 2017, the Akimat of Almaty in Kazakhstan hosted the official signing of a Memorandum on Curbing the Prices for Medicinal Products and Medical Devices.

The Memorandum became effective on May 23, 2017 and will be valid until the end of this year. The document was signed by the heads of leading pharmaceutical associations of Kazakhstan, including the Association for Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan, Association of International Pharmaceutical Manufacturers in Kazakhstan, Association of Pharmaceutical Distributors of the Republic of Kazakhstan, Association PharmMedIndustry of Kazakhstan.

The Memorandum sets fixed prices for 105 medicinal products and medical devices.

According to the document, the associations will curb the prices for medicinal products and medical devices by:

• conducting negotiations with local and foreign manufacturers, distributors and pharmacies on curbing the prices.
• setting fixed prices for 105 medicinal products and medical devices that are most frequently used by socially vulnerable and low-income population groups in accordance with the appendix to the Memorandum.

Source

Return